Jennifer K. Simpson

CIK 1545253 · President and CEO · last filed 2024-10-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$293.3K

Companies

4

Total Filings

29

Lifetime Open-Market Net

$20.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PBLA President and CEO 7,868 $0.01 $87 $0 4 2023-03-29
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Director $2.14 $0 5 2023-03-09
Panbela Therapeutics, Inc. (SNBP) Delisted President and CEO 3,424 $2.7K 2 2020-09-14
DCTH President and CEO 25,021 $11.72 $293.2K $17.7K 13 2020-05-08

Recent Filings · Page 3 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-08-02 DCTH Buy (P) +100 $255 EDGAR
2017-06-29 DCTH Tax (F) −468 -$102 EDGAR
2017-02-10 DCTH Grant (A) +31,250 $0 EDGAR
2016-06-17 DCTH Tax (F) −24,004 -$6.0K EDGAR
2015-06-12 DCTH Grant (A) +201,375 $0 EDGAR
2013-11-18 DCTH Grant (A) $0 EDGAR
2013-03-13 DCTH Grant (A) $0 EDGAR
2012-06-04 DCTH Buy (P) +3,000 $4.5K EDGAR
2012-03-26 DCTH Grant (A) +7,500 $0 EDGAR
Showing 2129 of 29
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.